Beyond Hyaluronic Acid: Bloomage Biotech Establishes China’s First Synthetic Biofund

6月 08, 2023

In early June, the China (Jinan) Hyaluronic Acid Industry Conference was held in Jinan, Shandong Province, China. During the conference, Bloomage Biotechnology (SH: 688363), a leading company in the hyaluronic acid industry, officially announced its Corporate Venture Capital (CVC) strategy and entered into a strategic cooperation agreement with Fuyuan Investment to jointly establish the first synthetic biofund in China.

*CVC refers to the investment activities conducted by enterprises through the establishment of venture capital departments or private equity venture capital funds, al …